23
Views
3
CrossRef citations to date
0
Altmetric
Articles

Effects of Oestradiol and the Oestrogen Antagonist lei 182,780 on the Delayed Type Hypersensitivity (DTH) Index and on Serum Levels of lgM and lgG in Ovariectomised Balb/C and MRL/Mp-Lpr/Lpr Mice, a Model of Systemic Lupus Erythematosus (SLE)

, , &
Pages 237-243 | Received 22 Jun 2000, Accepted 04 Apr 2000, Published online: 31 May 2017

References

  • Verheul HA, VerveId M, Hoefaldcer S and Schuurs AN. Effects of ethinyloestradiol on the course of spontaneous autoimmune disease in NZB/W and NOD mice. Immunop-harmacol Immunotoxicol 1995: 17: 163–180.
  • Theofilopoulos AN andDixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985: 37: 269–390.
  • Nadeau JH, Davisson MT, Doolittle DP, Grant P. Hillyard AL, Kosowsky M and Roderick TH. Comparative map for mice and humans. Mammalian Genome 1991: 1.
  • Watanabe-Fukunaga R, Brannan CI, Copeland NO, Jenkins NA and Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992: 356: 314–317.
  • Wu J, Thou T, He J and Mountz JD. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 1993: 178: 461–4688.
  • Carlsten H, Tarkowski A, Holmdahl Rand Nilsson LA. Oes-trogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin Exp Immunol 1990: 80: 467–473.
  • Carlsten H, Nilsson N, Jonsson R, Backman K, Holmdahl R and Tarkowski A. Oestrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice. Cell Immunol 1992: 144: 190-202.
  • Carlsten H, Holmdahl R and Tarkowski A. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) Fl mice. Immunology 1991: 73: 186–190.
  • Carlsten H, Holmdahl R, Tarkowski A and Nilsson LA. Oestradiol- and testosterone-mediated effects on the immune system in normal and autoimmune mice are genetically linked and inherited as dominant traits. Immunology 1989: 68: 209–214.
  • Walker SE, McMurray RW, Besch-Williford CL and Keisler DH. Premature death with bladder outlet obstruction and hyperprolactinemia in New Zealand black x New Zealand white mice treated with ethinyl oestradiol and 17-beta-oestradiol. Arth Rheum 1992: 35: 1387–1392.
  • Ratkay LG, Mang D, Tonzetich J, Levy JG and Waterfield JD. Evaluation of a model for post-partum arthritis and the role of oestrogen in prevention of MRL-Ipr associated rheu-matic conditions. Clin Exp Immunol 1994: 98: 52–59.
  • Greenstein BD, Dhaher YY, Bridges E de F, Keser G, Kha-mashta MA, Etherington 3 et al. Effects of an aromatase inhibitor on thymus and kidney and on oestrogen receptors in female MRL/MP-/pr//pr mice. Lupus 1993: 2: 221–225.
  • Mangelsdorf DJ, Thummel C, Beato M, Herrlich P. Schutz G, Umesono K, Blumberg B, Kastner P. Mark M, Chambon P and Evans RM. The nuclear receptor superfamily: the sec-ond decade. Cell 1995: 83: 835–839.
  • Couse IF, Lindzey J, Grandien K, Gustafsson J-A and Korach KS. Tissue distribution and quantitation analysis of oestrogen receptor-a (ER-a) and oestrogen receptor-13 (ER-p) messenger ribonucleic acid in the wild type and ER-a knockout mouse. Endocrinology 1997: 138: 4613–4621.
  • Roa, R and Greenstein BD. Evidence for pleomorphism of oestrogen receptor capacity and affinity in liver and thymus of immature BALB/c and (NZI3xNZW) Fl mice, a model of systemic lupus erythematosus. Intl. J. Immunopharmacol (in press).
  • Turken S. Sins E, Seldin D, Raster E, Hyman 0 and Lindey R. Effects of tamoxifen on spinal bone density in women with breast cancer. J Nall Cancer Inst 1989: 81: 1086–1088.
  • Dhaher YY, Chan K, Greenstein BD, de Fougerolles Nunn E, Khamashta, MA and Hughes, GRV. Impaired oestrogen priming of progesterone receptors in uterus of MRLI1v1P-lpr/lpr mice, a model of systemic lupus erythema-tosus (SLE). Int J Immunophatmacol. 2000: 22: 537–545.
  • Wakeling AE and Bowler J. ICI 182,780, a new antioestro-gen with clinical potential. J Steroid Biochem Mol Biol 1992: 43: 173–177.
  • Dukes M, Miller D, Wakeling AE and Waterton JC. Antiuter-otrophic effects of a pure antioestrogen, ICI 182,780: mag-netic resonance imaging of the uterus in ovariectomised monkeys. J Endocrinol 1992: 135: 239–247.
  • Taube M, Svensson Land Carlsten H. T lymphocytes are not the target for oestradiol-mediated suppression of D’TH in reconstituted female severe combined immunodificient (SCID) mice. Clin Exp Immunol 119: 114: 147-153.
  • Chai CK. Response of inbred and Fl hybrid mice to hor-mone. Nature 1960: 185: 514–518.
  • Apelgren LD, Bailey DL, Fouts RL, Short L, Bryan N, Evans GF et al, The effect of a selective oestrogen receptor modula-tor on the progression of spontaneous autoinunune disease in MRL lpr/lpr mice. Cellular Immunol 1996: 173: 55-63.
  • Dhaher YY, Greenstein D., Nunn E. de Fougerolles, Kha-mashta M and Hughes GRV. Strain differences in binding properties of oestrogen receptors in immature and adult BALB/c and MRLIMP-lpr/lpr mice, a model of systemic lupus erythematosus. Int J Immunopharmacol 2000: 22: 247–254.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.